[EN] CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS<br/>[FR] DÉRIVÉS DE CYCLOAMINO COMME ANTAGONISTES DU GPR119
                        
                            
                                申请人:PROSIDION LTD
                            
                            
                                公开号:WO2011147951A1
                            
                            
                                公开(公告)日:2011-12-01
                            
                            Therapeutic compounds are disclosed having the general formula (I) that are useful for the treatment of metabolic disorders, including type II diabetes. The compounds have activity as agonists of GPR119. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity.